HC Wainwright & Co. Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target

Assembly Biosciences, Inc.

Assembly Biosciences, Inc.

ASMB

0.00

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Assembly Biosciences (NASDAQ: ASMB) with a Buy and maintains $50 price target.